These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23944125)

  • 21. Self-regulation and inhibition in comorbid ADHD children: an evaluation of executive functions.
    Sarkis SM; Sarkis EH; Marshall D; Archer J
    J Atten Disord; 2005 Feb; 8(3):96-108. PubMed ID: 16009658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology.
    Alexander JL; Dennerstein L; Kotz K; Richardson G
    Expert Rev Neurother; 2007 Nov; 7(11 Suppl):S45-58. PubMed ID: 18039068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.
    Rowland AS; Lesesne CA; Abramowitz AJ
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):162-70. PubMed ID: 12216060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comorbidity characteristics in the different subtypes of attention deficit-hyperactivity disorder].
    Flores Lázaro JC
    Psicothema; 2009 Nov; 21(4):592-7. PubMed ID: 19861104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders.
    Rosenbluth M; Macqueen G; McIntyre RS; Beaulieu S; Schaffer A;
    Ann Clin Psychiatry; 2012 Feb; 24(1):56-68. PubMed ID: 22303522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More on mood disorders in youth.
    Wagner KD
    J Clin Psychiatry; 2012 Oct; 73(10):1326-7. PubMed ID: 23140651
    [No Abstract]   [Full Text] [Related]  

  • 28. Developmental disabilities across the lifespan.
    Patel DR; Greydanus DE; Calles JL; Pratt HD
    Dis Mon; 2010 Jun; 56(6):304-97. PubMed ID: 20515667
    [No Abstract]   [Full Text] [Related]  

  • 29. The ESSENCE in child psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations.
    Gillberg C
    Res Dev Disabil; 2010; 31(6):1543-51. PubMed ID: 20634041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From single to multiple deficit models of developmental disorders.
    Pennington BF
    Cognition; 2006 Sep; 101(2):385-413. PubMed ID: 16844106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
    Hornig M
    J Clin Psychiatry; 1998; 59 Suppl 7():69-75. PubMed ID: 9680055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comorbidity of psychiatric disorders and parental psychiatric disorders in a sample of Iranian children with ADHD.
    Ghanizadeh A; Mohammadi MR; Moini R
    J Atten Disord; 2008 Sep; 12(2):149-55. PubMed ID: 18319376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbidity in children and adolescent psychiatry.
    Burgić-Radmanović M; Burgić S
    Psychiatr Danub; 2010 Jun; 22(2):298-300. PubMed ID: 20562768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population.
    Smalley SL; McGough JJ; Moilanen IK; Loo SK; Taanila A; Ebeling H; Hurtig T; Kaakinen M; Humphrey LA; McCracken JT; Varilo T; Yang MH; Nelson SF; Peltonen L; Järvelin MR
    J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1575-83. PubMed ID: 18030079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preschool boys with oppositional defiant disorder: clinical presentation and diagnostic change.
    Speltz ML; McClellan J; DeKlyen M; Jones K
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):838-45. PubMed ID: 10405501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
    Levin FR
    J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders.
    McIntyre RS; Alsuwaidan M; Goldstein BI; Taylor VH; Schaffer A; Beaulieu S; Kemp DE;
    Ann Clin Psychiatry; 2012 Feb; 24(1):69-81. PubMed ID: 22303523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The difficult child syndrome].
    Shoval G; Manor I; Tyano S
    Harefuah; 2005 Jan; 144(1):29-33, 70. PubMed ID: 15719819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds.
    Fergusson DM; Horwood LJ; Lynskey MT
    J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1127-34. PubMed ID: 8282656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.